Try
Anika Therapeutics Inc. Common Stock
ANIKUnited States
5 filed reports · 287 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 915 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 809 | Dec 2025 |
Financial data
287 concepts · 1,724 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial270 concepts · 1,602 facts · Dec 2023 to Jun 2026
- Stockholders equity (US GAAP)14 · Dec 2023 to Jun 2026
- Adjustments related to tax withholding for share based compensation13 · Dec 2023 to Jun 2026
- Allowance for doubtful accounts receivable13 · Dec 2023 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations13 · Dec 2023 to Jun 2026
- Net income loss13 · Dec 2023 to Jun 2026
- Other comprehensive income loss net of tax13 · Dec 2023 to Jun 2026
- Stock-based compensation expense13 · Dec 2023 to Jun 2026
- Stock issued during period value restricted stock award net of forfeitures13 · Dec 2023 to Jun 2026
- Comprehensive income net of tax12 · Dec 2023 to Jun 2026
- Cost of goods and services sold (US GAAP)12 · Dec 2023 to Jun 2026
- Depreciation12 · Dec 2023 to Jun 2026
- Gross profit (US GAAP)12 · Dec 2023 to Jun 2026
- Income tax expense benefit12 · Dec 2023 to Jun 2026
- Interest income expense nonoperating net12 · Dec 2023 to Jun 2026
- Operating income loss12 · Dec 2023 to Jun 2026
- Other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent12 · Dec 2023 to Jun 2026
- Research and development expense12 · Dec 2023 to Jun 2026
- Revenue12 · Dec 2023 to Jun 2026
- Selling general and administrative expense12 · Dec 2023 to Jun 2026
- Allowance for doubtful accounts receivable recoveries11 · Dec 2023 to Jun 2026
- Amortization of acquisition related intangible assets11 · Dec 2023 to Jun 2026
- Capital expenditures incurred but not yet paid11 · Dec 2023 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect11 · Dec 2023 to Jun 2026
- Deferred income tax expense benefit11 · Dec 2023 to Jun 2026
Geography2 concepts · 66 facts · Dec 2023 to Jun 2026
- Revenue36 · Dec 2023 to Jun 2026
- Percentage of Revenue30 · Dec 2023 to Jun 2026
Product2 concepts · 30 facts · Dec 2023 to Jun 2026
- Revenue24 · Dec 2023 to Jun 2026
- Percentage of Revenue6 · Dec 2023 to Dec 2025
Segment13 concepts · 26 facts · Jun 2025 to Jun 2026
- Cost of goods and services sold (US GAAP)2 · Jun 2025 to Jun 2026
- Costs and expenses2 · Jun 2025 to Jun 2026
- Gross profit (US GAAP)2 · Jun 2025 to Jun 2026
- Income loss from continuing operations2 · Jun 2025 to Jun 2026
- Income loss from continuing operations before income taxes extraordinary items noncontrolling interest2 · Jun 2025 to Jun 2026
- Income loss from discontinued operations net of tax attributable to reporting entity2 · Jun 2025 to Jun 2026
- Income tax expense benefit2 · Jun 2025 to Jun 2026
- Interest income expense nonoperating net2 · Jun 2025 to Jun 2026
- Net income loss2 · Jun 2025 to Jun 2026
- Operating income loss2 · Jun 2025 to Jun 2026
- Research and development expense2 · Jun 2025 to Jun 2026
- Revenue2 · Jun 2025 to Jun 2026
- Selling general and administrative expense2 · Jun 2025 to Jun 2026
Segments
122 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement geographical3 members · 66 facts
- Europe22 · Dec 2023 to Jun 2026
- Other Location22 · Dec 2023 to Jun 2026
- US22 · Dec 2023 to Jun 2026
Product or service2 members · 30 facts
- Commercial Channel15 · Dec 2023 to Jun 2026
- OEM Channel15 · Dec 2023 to Jun 2026
Statement business segments1 member · 26 facts
- Single Reportable26 · Jun 2025 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Nov 2025 to Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 29, 2026
- FY2026 Q1Apr 29, 2026
- FY2025 Q4Feb 26, 2026
- FY2025 Q3Nov 5, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.